CONSOLIDATED STATEMENTS OF CASH FLOWS € in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2025 USD ($)	Mar. 31, 2024 USD ($)
OPERATING ACTIVITIES
Net income including noncontrolling interest	$ 406.5	$ 416.6
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	161.2	157.0
Amortization	74.9	77.8
Deferred income taxes	(21.0)	(74.4)
Share-based compensation expense	42.2	47.0
Pension and postretirement plan contributions	(15.6)	(15.3)
Pension and postretirement plan (income) expense, net	3.4	4.0
Restructuring charges, net of cash paid	21.8	0.2
Sale of global surgical solutions business	1.1
Other, net	(4.4)	1.5
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(9.1)	49.0
Inventories	(69.1)	(65.5)
Other assets	(29.9)	21.3
Accounts payable	(2.5)	82.7
Other liabilities	(190.1)	(52.5)
Cash provided by operating activities	369.4	649.4
INVESTING ACTIVITIES
Capital expenditures	(237.9)	(201.5)
Property and other assets sold	21.6	0.7
Divestiture of businesses, net of cash divested	(14.9)
Other, net	7.2	(0.2)
Cash used for investing activities	(224.0)	(201.0)
FINANCING ACTIVITIES
Net issuances (repayments) of commercial paper and notes payable	4.5	7.2
Long-term debt repayments		(629.6)
Reacquired shares	(153.7)	(196.4)
Dividends paid	(192.0)	(175.2)
Exercise of employee stock options	98.5	105.5
Other, net	1.1	(0.8)
Cash used for financing activities	(241.6)	(889.3)
Effect of exchange rate changes on cash and cash equivalents	2.0	1.3
Increase in cash and cash equivalents	(94.2)	(439.6)
Cash and cash equivalents, beginning of period	1,256.8	919.5
Cash and cash equivalents, end of period	$ 1,162.6	$ 479.9